Skip to content
Clinical Trials – home

Diab Serwis Popenda Sp. j.

Verified siteinfo

Poland Ul. Jozefa Ryszki 51, 41-516 Chorzow, Poland

  • 2 trials recruiting
  • Type 2 diabetes mellitus · Arteriosclerosis · Graves' disease
  • Adult patients

About Specializations

Diab Serwis Popenda Sp. j. in Chorzow, Poland specialises in clinical trials of conditions such as Type 2 diabetes mellitus, Arteriosclerosis, Graves' disease, Obesity, and other specialisations. This site conducts important research.

Main research areas of the site

Immune System Diseases Research

At Diab Serwis Popenda Sp. j. in Chorzow, clinical research in immune system diseases focuses on Graves’ disease, with studies aimed at understanding and improving control of thyroid autoimmunity and hormone balance.

  • Evaluating new treatment options for Graves’ disease and related thyroid dysfunction
  • Measuring how well therapies help maintain euthyroidism and reduce the need for ongoing anti-thyroid treatment
  • Assessing the effectiveness and safety of investigational approaches for autoimmune thyroid disease

These trials are designed to support better long-term disease management and to explore more durable ways to control symptoms in people living with Graves’ disease.

Nutritional and Metabolic Diseases Research

The site also conducts studies in nutritional and metabolic diseases, mainly centered on type 2 diabetes and cases where blood sugar remains difficult to control despite current treatment.

  • Testing new combinations intended to improve HbA1c and overall glucose control in type 2 diabetes
  • Comparing treatment strategies for people with inadequate response to dapagliflozin with or without metformin
  • Studying therapies that may also support body weight improvement alongside better metabolic control

These diabetes trials aim to identify more effective ways to manage long-term blood sugar levels and improve outcomes for patients with persistent type 2 diabetes challenges.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ul. Jozefa Ryszki 5141-516 ChorzowPoland
Recruiting now
2 trials
Conditions studied
5
Partner status
Verified site

More sites in ChorzowPoland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

10 clinical trials

Graves' disease

Recruiting

Long-Term Study of Imeroprubart in Adults With Graves' Disease

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Imeroprubart
  • Sponsor:Immunovant Sciences GmbH

Graves' disease

Recruiting

Study of IMVT-1402 Treatment for Adults with Graves' Disease

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Imeroprubart
  • Sponsor:Immunovant Sciences GmbH

Type 2 diabetes mellitus

Not yet recruiting

Study of zenagamtide versus insulin glargine in adults with type 2 diabetes and high cardiovascular risk uncontrolled on oral medications

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Insulin Glargine
  • Sponsor:Novo Nordisk A/S

Arteriosclerosis

Not recruiting

Study on the Effect of Obicetrapib in Patients with Atherosclerotic Cardiovascular Disease Not Adequately Managed by Current Lipid-Lowering Treatments

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Obicetrapib
  • Sponsor:NewAmsterdam Pharma B.V.

Atrial fibrillation

Not recruiting

Study on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Andexanet Alfa
  • Sponsor:Janssen Cilag International

Arteriosclerosis

Not recruiting

Study on Inclisiran for Preventing Heart Disease in High-Risk Patients

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Inclisiran
  • Sponsor:Novartis Pharma AG

Obesity

Not recruiting

Comparing the efficacy and safety of KAI-9531 and semaglutide in people living with obesity who do not have diabetes

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:HRS 9531

Study comparing cagrilintide and semaglutide versus tirzepatide in people with type 2 diabetes taking metformin or SGLT2 inhibitor

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S

Study on the Effectiveness and Safety of Gliclazide MR, Dapagliflozin, and Metformin for Patients with Type 2 Diabetes Not Well Controlled with Dapagliflozin

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin
  • Sponsor:Institut De Recherches Internationales Servier IRIS
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.